Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2521-2527

  Frank, Douglas K ^a   Frederick, Mitchell J ^a   Liu, Ta Jen ^a   Clayman, Gary L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS RECOMBINANT;

ADENOVIRIDAE; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; GENE THERAPY; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; TUMOR CELLS, CULTURED;

EID: 0031755588     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther., 4: 725-731, 1993.
2. Chen, C. Y., Chang, Y. N., Ryan, P., Linscott, M., McGarrity, G. J., and Chiang, Y. L. Effect of herpes simplex thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect." Hum. Gene Ther., 6: 1467-1476, 1995.
3. Hamel, W., Magnelli, L., Chiarugi, V. P., and Israel, M. A. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res., 56: 2697-2702, 1996.
4. Kuriyama, S., Nakatani, T., Masui, K., Sakamoto, T., Tominaga, K., Yoshikawa, M., Fukui, H., Ikenaka, K., and Tsujii, T. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology, 22: 1838-1846, 1995.
5. Wilson, K. M., Stambrook, P. J., Bi, W. L., Pavelic, Z. P., Pavelic, L., and Gluckman, J. L. Hsv-tk gene therapy in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 122: 746-749, 1996.
6. Wu, J. K., Cano, W. G., Meylaerts, S. A. G., Qi, P., Vrionis, F., and Cherington, V. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery, 35: 1094-1103, 1994.
7. Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., and Yamasaki, H. Bystander killing of cancer cells by herpes simplex thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. USA, 93: 1831-1835, 1996.
8. Mesnil, M., Piccoli, C., and Yamasaki, H. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res., 57: 2929-2932, 1997.
9. Pitts, J. D. Cancer gene therapy: a bystander effect using the gap junction pathway. Mol. Carcinog., 11: 127-130, 1994.
10. Clayman, G. L., El-Naggar, A. K., Roth, J. A., Zhang, W. W., Goepfert, H., Taylor, D. L., and Liu, T. J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
11. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
12. Liu, T. J., El-Naggar, A. K., McDonnell, T. J., Steck, K. D., Wang, M., Taylor, D. L., and Clayman, G. L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
13. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., and Ullrich, S. J. Negative growth regulation in a glioblastoma cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
14. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
15. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
16. Cai, D. W., Mukhopadhyay, T., Yongjian, L., Fujiwara, T., and Roth, J. A. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum. Gene Ther., 4: 617-624, 1993.
17. Fujiwara, T., Cai, D. W., Georges, R. N., Mukhopadhyay, T., Grimm, E. A., and Roth, J. A. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthoptic lung cancer model. J. Natl. Cancer Inst., 86: 1458-1462, 1994.
18. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M. W., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C. I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 9: 985-991, 1996.
19. Pirollo, K. F., Hao, Z., Rait, A., Jang, Y. J., Fee, W. F., Ryan, P., Chiang, Y., and Chang, E. p53-mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene, 14: 1735-1746, 1997.
20. Liu, T. J., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
21. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., and Prasher, D. C. Green fluorescent protein as a marker for gene expression. Science (Washington DC), 263: 802-805, 1994.
22. Lo, C. W. The role of gap junction membrane channels in development. J. Bioenerg. Biomembr., 28: 379-385, 1996.
23. Sivak, A., and Van Duuren, B. L. Phenotypic expression of transformation induction in cell culture by a phorbol ester. Science (Washington DC), 157: 1443-1444, 1967.
24. Yamasaki, H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis (Lond.), 11: 1051-1058, 1990.
25. El-Fouly, M. H., Trosko, J. E., and Chang, C. C. Scrape loading and dye transfer. A rapid technique to study gap junctional intercellular communication. Exp. Cell Res., 168: 422-430, 1987.
26. Davidson, J. S., Baumgarten, I. M., and Harley, E. H. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem. Biophys. Res. Commun., 134: 29-36, 1986.
27. Holder, J. W., Elmore, E., and Barrett, J. C. Gap junction function and cancer. Cancer Res., 53: 3475-3485, 1993.
28. Mesnil, M., and Yamasaki, H. Cell-cell communication and growth control of normal and cancer cells: evidence and hypothesis. Mol. Carcinog., 7: 14-17, 1993.
29. Charles, A. C., Naus, C. C. G., Zhu, D., Kidder, G. M., Dirksen, E. R., and Sanderson, M. J. Intercellular calcium signaling via gap junctions in glioma cells. J. Cell Biol., 118: 195-201, 1992.
30. Saez, J. C., Connor, J. A., Spray, D. C., and Bennett, M. V. L. Hepatocyte gap junctions are permeable to the second messenger, inositol 1,4,5-triphosphate, and to calcium ions. Proc. Natl. Acad. Sci. USA, 86: 2708-2712, 1989.